Financial Advisory Group Abb Vie Inc. Transaction History

Financial Advisory Group

$552 Million
Q1 2024

A detailed history of Financial Advisory Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Advisory Group holds 4,322 shares of ABBV stock, worth $758,856. This represents 0.14% of its overall portfolio holdings.

Number of Shares

4,322

Previous 4,348 0.6%

Holding current value

$758,856

Previous $673,000 16.94%

% of portfolio

0.14%

Previous 0.13%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $4,155 - $4,734	-26 Reduced 0.6%	4,322 $787,000
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $13,760 - $15,497	100 Added 2.35%	4,348 $673,000
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $19,086 - $22,890	-138 Reduced 3.15%	4,248 $687,000
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $8,314 - $10,316	63 Added 1.46%	4,386 $711,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $18,585 - $23,515	173 Added 4.17%	4,323 $585,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $3,436 - $4,033	-40 Reduced 0.95%	4,150 $363,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $10,271 - $13,745	140 Added 3.46%	4,190 $411,000
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $4,837 - $7,334	-75 Reduced 1.82%	4,050 $309,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $37,788 - $45,432	-600 Reduced 12.7%	4,125 $312,000
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $41,062 - $52,487	625 Added 15.24%	4,725 $323,000
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $7,714 - $9,079	100 Added 2.5%	4,100 $330,000
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $26,934 - $31,869	300 Added 8.11%	4,000 $371,000
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $9,201 - $12,321	100 Added 2.78%	3,700 $350,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $17,912 - $19,642	200 Added 5.88%	3,600 $348,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $237,489 - $303,348	3,400	3,400 $302,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Group with notifications on news.

Account

Financial Advisory Group Abb Vie Inc. Transaction History